Pasithea Therapeutics Corp Stock Alpha and Beta Analysis
| KTTAW Stock | USD 0.02 0 11.11% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Pasithea Therapeutics Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Pasithea Therapeutics over a specified time horizon. Remember, high Pasithea Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Pasithea Therapeutics' market risk premium analysis include:
Beta 1.94 | Alpha 5.44 | Risk 179.85 | Sharpe Ratio 0.19 | Expected Return 33.63 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Pasithea |
Pasithea Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Pasithea Therapeutics market risk premium is the additional return an investor will receive from holding Pasithea Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Pasithea Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Pasithea Therapeutics' performance over market.| α | 5.44 | β | 1.94 |
Pasithea Therapeutics Fundamentals Vs Peers
Comparing Pasithea Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Pasithea Therapeutics' direct or indirect competition across all of the common fundamentals between Pasithea Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Pasithea Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Pasithea Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Pasithea Therapeutics to competition |
| Fundamentals | Pasithea Therapeutics | Peer Average |
| Return On Equity | -0.63 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Number Of Shares Shorted | 64 | 4.71 M |
| Revenue | 486.56 K | 9.43 B |
| EBITDA | (15.33 M) | 3.9 B |
| Net Income | (15.51 M) | 570.98 M |
| Cash And Equivalents | 568.98 K | 2.7 B |
Pasithea Therapeutics Opportunities
Pasithea Therapeutics Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety ... - StockTitan | 06/13/2024 |
2 | Biotech Stock Pasithea Therapeutics Corp. Soars on Positive Data from Phase 1 Clinical Trials - Investorideas.com newswire | 09/26/2024 |
3 | Pasithea Therapeutics announces SRC recommended proceeding to cohort 4 - TipRanks | 11/20/2024 |
About Pasithea Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Pasithea or other stocks. Alpha measures the amount that position in Pasithea Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2022 | 2023 (projected) | PB Ratio | 203.23 | 0.38 | 0.4 | Capex To Depreciation | 15.59 | 66.06 | 5.3E-5 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pasithea Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pasithea Therapeutics' short interest history, or implied volatility extrapolated from Pasithea Therapeutics options trading.
Build Portfolio with Pasithea Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Pasithea Stock Analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.